225 research outputs found

    Controlling Grain Size in Cold Worked and Annealed 1100 Aluminum to Optimize Ductility in Rocket Diaphragm Systems

    Get PDF
    Liquid propellant rocket diaphragms require extreme ductility. 1100 Aluminum is used for its high ductility, but the post-processing cold work and subsequent anneal result in excessively large grains. The effect of heat treatment and cold work on grain size in 1100 aluminum was explored. The samples were cold worked to 0, 5, 10, 15 and 30% using tensile elongation. The samples were then heat treated per AMS 2770 with either a Steel Conduction (1000 – 1150°F/min) or a Production (16 – 18°F/min) heating rate. The grain size of the samples were measured using the mean lineal intercept method. The grain diameter ranged from 81 – 189 μm for the Production rate and 83 – 209 μm for the Steel Conduction rate. The 15% cold worked Production rate samples were found to have significantly larger grains than those of the smaller cold work amounts as well as the 15% cold worked Steel Conduction rate samples. This indicated an interaction between the 15% cold work amount and the Production heat treatment which allowed for significant grain growth. The 30% cold worked samples were found to have grain growth in both heat treatments with the largest average grain diameters. The results indicate that the longer times at elevated temperatures during the Production heat treatment allow for significant grain growth at lower cold work amounts. In addition, grain growth is unavoidable for 30% cold work regardless of heating rate

    Le point de vue des patients sur le degré de participation des résidents en salle d’opération dans le cas d’une arthroplastie totale de la hanche ou du genou

    Get PDF
    Introduction: Previous work suggests that patients do not understand the extent of trainee involvement in their care and are uncomfortable with trainee involvement. Methods: We recruited 202 English speaking patients with previous or planned total joint arthroplasty of the lower limb for a prospective survey trial. We assessed participant’s knowledge of trainee level of education and confidence of trainee involvement in their surgery as a function of supervision. Results: Participants’ mean level of confidence in the consultant surgeon was 4.30 (SD±1.13) on a 5-point Likert scale. Confidence in residents was significantly less, regardless of resident experience (p < 0.05). 11.1% of participants did not want trainees involved in their treatment.  60.6% would like to know more about the education level of the trainee. Less than half of participants correctly identified the education level of residents and fellows. Conclusion: Patient confidence in trainees performing part or all of their surgery increases with resident experience and supervision. Most patients do not understand the hierarchy in education of medical trainees and would like to know more about the education level of the trainee involved in their care. Further work should explore how we can help patients better understand trainee involvement in their surgical care.Contexte: Des travaux antĂ©rieurs suggèrent que les patients ne comprennent pas le degrĂ© de participation des stagiaires dans leurs soins et que cette participation les rend mal Ă  l’aise. MĂ©thodes : Nous avons recrutĂ© 202 patients anglophones qui ont eu ou qui vont avoir une arthroplastie totale du membre infĂ©rieur pour un essai prospectif par sondage. Nous avons Ă©valuĂ© les connaissances des participants sur le niveau de formation des rĂ©sidents et leur confiance dans la participation des stagiaires dans l’intervention en fonction de la supervision dont ils font l’objet. RĂ©sultats : Le niveau moyen de confiance des participants dans le chirurgien consultant Ă©tait de 4,30 (SD±1,13) sur une Ă©chelle de Likert Ă  5 points. Le degrĂ© de confiance dans les rĂ©sidents Ă©tait bien infĂ©rieur, quelle que soit l’expĂ©rience du rĂ©sident (p < 0,05). Parmi les participants, 11,1 % ne voulaient pas que les rĂ©sidents interviennent dans leur traitement et 60,6 % souhaitaient en savoir plus sur leur niveau de formation. Moins de la moitiĂ© des participants ont correctement identifiĂ© le niveau de formation des rĂ©sidents et des fellows. Conclusion : La confiance des patients par rapport au fait que les stagiaires effectuent une partie ou la totalitĂ© de l’intervention chirurgicale augmente avec l’expĂ©rience et la supervision des rĂ©sidents. La plupart des patients ne comprennent pas les niveaux de formation des stagiaires en mĂ©decine et voudraient en savoir plus sur celui du mĂ©decin en formation qui intervient dans leurs soins. Des Ă©tudes plus poussĂ©es s’imposent sur la manière d’aider les patients Ă  mieux comprendre la participation des stagiaires dans les soins chirurgicaux

    The prevalence of potentially modifiable functional deficits and the subsequent use of occupational and physical therapy by older adults with cancer

    Get PDF
    Occupational and physical therapy (OT/PT) services seek to reduce morbidity, mortality, and improve the quality of life of individuals; however, little is known about the needs and use of OT/PT for older adults with cancer. The goal of this study was to describe the functional deficits and their associations with other factors, and to examine the use of OT/PT after a noted functional deficit

    AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice.

    Get PDF
    INTRODUCTION: Pathologic accumulation and activation of mast cells and eosinophils are implicated in allergic and inflammatory diseases. Sialic acid-binding immunoglobulin-like lectin (Siglec)-8 is an inhibitory receptor selectively expressed on mast cells, eosinophils and, at a lower extent, basophils. When engaged with an antibody, Siglec-8 can induce apoptosis of activated eosinophils and inhibit mast cell activation. AK002 is a humanized, non-fucosylated IgG1 anti-Siglec-8 antibody undergoing clinical investigation for treatment of allergic, inflammatory, and proliferative diseases. Here we examine the human tissue selectivity of AK002 and evaluate the in vitro, ex vivo, and in vivo activity of AK002 on eosinophils and mast cells. METHODS: The affinity of AK002 for Siglec-8 and CD16 was determined by biolayer interferometry. Ex vivo activity of AK002 on human eosinophils from blood and dissociated human tissue was tested in apoptosis and antibody-dependent cell-mediated cytotoxicity (ADCC) assays. The in vivo activity of a murine precursor of AK002 (mAK002) was tested in a passive systemic anaphylaxis (PSA) humanized mouse model. RESULTS: AK002 bound selectively to mast cells, eosinophils and, at a lower level, to basophils in human blood and tissue and not to other cell types examined. AK002 induced apoptosis of interleukin-5-activated blood eosinophils and demonstrated potent ADCC activity against blood eosinophils in the presence of natural killer cells. AK002 also significantly reduced eosinophils in dissociated human lung tissue. Furthermore, mAK002 prevented PSA in humanized mice through mast cell inhibition. CONCLUSION: AK002 selectively evokes potent apoptotic and ADCC activity against eosinophils and prevents systemic anaphylaxis through mast cell inhibition

    AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice

    Get PDF
    INTRODUCTION: Pathologic accumulation and activation of mast cells and eosinophils are implicated in allergic and inflammatory diseases. Sialic acid-binding immunoglobulin-like lectin (Siglec)-8 is an inhibitory receptor selectively expressed on mast cells, eosinophils and, at a lower extent, basophils. When engaged with an antibody, Siglec-8 can induce apoptosis of activated eosinophils and inhibit mast cell activation. AK002 is a humanized, non-fucosylated IgG1 anti-Siglec-8 antibody undergoing clinical investigation for treatment of allergic, inflammatory, and proliferative diseases. Here we examine the human tissue selectivity of AK002 and evaluate the in vitro, ex vivo, and in vivo activity of AK002 on eosinophils and mast cells. METHODS: The affinity of AK002 for Siglec-8 and CD16 was determined by biolayer interferometry. Ex vivo activity of AK002 on human eosinophils from blood and dissociated human tissue was tested in apoptosis and antibody-dependent cell-mediated cytotoxicity (ADCC) assays. The in vivo activity of a murine precursor of AK002 (mAK002) was tested in a passive systemic anaphylaxis (PSA) humanized mouse model. RESULTS: AK002 bound selectively to mast cells, eosinophils and, at a lower level, to basophils in human blood and tissue and not to other cell types examined. AK002 induced apoptosis of interleukin-5-activated blood eosinophils and demonstrated potent ADCC activity against blood eosinophils in the presence of natural killer cells. AK002 also significantly reduced eosinophils in dissociated human lung tissue. Furthermore, mAK002 prevented PSA in humanized mice through mast cell inhibition. CONCLUSION: AK002 selectively evokes potent apoptotic and ADCC activity against eosinophils and prevents systemic anaphylaxis through mast cell inhibition

    Quality of Life Changes during the Pre- to Post-Diagnosis Period and Treatment-Related Recovery Time in Older Women with Breast Cancer

    Get PDF
    Healthcare providers have little population-based evidence about health-related quality of life (HRQOL) changes, from the pre- to post-diagnosis period, and treatment-related recovery time for women ages 65 and older diagnosed with breast cancer
    • …
    corecore